Christopher Ianelli serves as Executive at iSpecimen Inc., where they oversee executive responsibilities. Since joining the company, Christopher Ianelli has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 6, 2023 involved exercising options for 845 shares valued at $845.
Christopher Ianelli currently holds 425,359 shares of iSpecimen Inc. (ISPC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Ianelli has been a net neutral trader of ISPC stock. They have purchased $0 and sold $0 worth of shares.
Christopher Ianelli's most recent insider trade was on Jan 6, 2023, when they sold 845 shares at $1.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 24, 2022 | ISPC | $0 | Other | 18,229 | $N/A | Discretionary |
| Jun 22, 2022 | ISPC | $9.2K | Payment | 3,903 | $2.36 | Discretionary |
| Feb 23, 2022 | ISPC | $48.1K | Option Exercise | 48,106 | $1.00 | Discretionary |
| Feb 22, 2022 | ISPC | $3.1K | Option Exercise | 3,099 | $1.00 | Discretionary |
| Jul 30, 2021 | ISPC | $0 | Award | 52,084 | $N/A | Discretionary |
| Jun 21, 2021 | ISPC | $0 | Conversion | 2,663 | $N/A | Discretionary |